We use cookies, including third-party cookies from Google to serve personalized ads through AdSense, to operate this site and understand how it is used. By continuing to browse, you accept this use. See our Privacy Policy and Terms of Use for details, including how to opt out of personalized advertising.
Accept
Health Works CollectiveHealth Works CollectiveHealth Works Collective
  • Health
    • Mental Health
  • Policy and Law
    • Global Healthcare
    • Medical Ethics
  • Medical Innovations
  • News
  • Wellness
  • Tech
Search
© 2023 HealthWorks Collective. All Rights Reserved.
Reading: A Victory for Coverage with Evidence Development
Share
Notification Show More
Font ResizerAa
Health Works CollectiveHealth Works Collective
Font ResizerAa
Search
Follow US
  • About
  • Contact
  • Privacy
© 2023 HealthWorks Collective. All Rights Reserved.
Health Works Collective > Technology > Medical Devices > A Victory for Coverage with Evidence Development
BusinessMedical Devices

A Victory for Coverage with Evidence Development

gooznews
gooznews
Share
3 Min Read
SHARE

A federal study of a new stent designed to prevent repeat strokes was stopped early because 2 1/2 times (14.7%) more people either died or had a repeat stroke after receiving the stent than those who received drugs and counseling (5.8%). The $20 million study, stopped after just 451 stroke victims had been enrolled because of the alarming trend in the results, was sponsored by the National Institute of Neurological Diseases and Stroke.

A federal study of a new stent designed to prevent repeat strokes was stopped early because 2 1/2 times (14.7%) more people either died or had a repeat stroke after receiving the stent than those who received drugs and counseling (5.8%). The $20 million study, stopped after just 451 stroke victims had been enrolled because of the alarming trend in the results, was sponsored by the National Institute of Neurological Diseases and Stroke.

The Gateway-Wingspan system, manufactured by Stryker, was approved by the Food and Drug Administration in 2005 based on “a small, less rigorous study,” according to this morning’s Washington Post. But use has been limited by a decision by the Centers for Medicare and Medicaid Services to deny reimbursement unless patients receiving the device were enrolled in a clinical trial. This “coverage with evidence development” policy began during former CMS director Mark McClellan’s tenure during the Bush administration.

Walter Koroshetz, chief of NIHDK, told the Post, “This is an example of how to do it right.” I partially agree. The government did the right thing, given existing laws and policies. But Stryker should have done the larger trial in the first place. The potential profits from the device, if it was useful, would have far exceeded the $20 million spent by the government to prove it wasn’t.

More Read

7 Healthcare Cybersecurity Tips To Protect Your Data
The Global Budget in Your Future
How to Help Patients Find Your Medical Practice Easily Online
Massachusetts Medical School Wins Contract to Design Health Insurance Exchanges
Face to Face Virtual Clinic Consults with Optum Doctors and Nurses For $45.00

The company should be asked to reimburse the taxpayers. And this episode shows that the FDA’s device approval process should be made more stringent to require the same kind of trials for devices that it now requires of drugs — the trials that prove with statistical significance that new products do in fact improve public health.

TAGGED:coverage with evidenceFDAgateway-wingspanstent
Share This Article
Facebook Copy Link Print
Share

Stay Connected

1.5KFollowersLike
4.5KFollowersFollow
2.8KFollowersPin
136KSubscribersSubscribe

Latest News

Flat editorial illustration: Health-editorial illustration of the two-way relationship between substance use and disrupted sleep,
How Sleep Disruption Feeds the Addiction Cycle and What You Can Do About It
Addiction Recovery Mental Health Wellness
November 6, 2026
Flat editorial illustration: The article connects routine visual inspection and accurate barrier fit with protection of peristoma
Peristomal Skin Care: Healthy Skin, Irritation Causes, and When to See a WOC Nurse
Health Nursing
November 2, 2026
Flat editorial illustration: Clinical-trial operations editorial illustration combining healthcare and technology: country-specif
Clinical Study Operations Across Eastern European Research Markets
Health
October 31, 2026
Flat editorial illustration: A health-editorial scene of a first pain-management visit, bringing together attentive consultation,
What to Expect at Your First Pain Management Appointment
Therapies Wellness
October 29, 2026

You Might also Like

health economics
BusinessFinancePolicy & Law

The Sorry State of Health Economics

March 18, 2014
high quality, low cost healthcare
BusinessPublic HealthWellness

High Quality, Low Cost HealthCare Video Interview Series: Herbert Ong from Healthentic Talks Corporate Wellness

February 26, 2013
BusinessMedical InnovationsTechnology

Healthcare Costs Involved in Finding the Right Recovery Program

December 13, 2016
health IT HIMSS 2014
BusinessTechnology

Practical Advice for HIMSS 2014 Attendees

February 21, 2014
Subscribe
Subscribe to our newsletter to get our newest articles instantly!
Follow US
© 2008-2026 HealthWorks Collective. All Rights Reserved.
  • About
  • Contact
  • Privacy
Welcome Back!

Sign in to your account

Username or Email Address
Password

Lost your password?